tiprankstipranks
Trending News
More News >
Bionexus Gene Lab Corporation (BGLC)
:BGLC
US Market

BioNexus Gene Lab Corp (BGLC) Financial Statements

Compare
79 Followers

BioNexus Gene Lab Corp Financial Overview

BioNexus Gene Lab Corp's market cap is currently $4.98M. The company's EPS TTM is $-0.888; its P/E ratio is ―; BioNexus Gene Lab Corp is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 9.51M$ 9.77M$ 10.93M$ 13.36M$ 11.39M
Gross Profit$ 1.29M$ 1.33M$ 1.26M$ 2.19M$ 1.72M
Operating Income$ -1.57M$ -2.59M$ -291.18K$ 1.06M$ 1.27M
EBITDA$ -1.42M$ -2.49M$ -185.76K$ 1.16M$ 1.38M
Net Income$ -1.60M$ -2.63M$ -355.97K$ 751.57K$ 1.09M
Balance Sheet
Cash & Short-Term Investments$ 1.58M$ 5.93M$ 2.12M$ 2.12M$ 2.79M
Total Assets$ 10.43M$ 11.40M$ 8.74M$ 9.57M$ 10.12M
Total Debt$ 210.56K$ 133.40K$ 56.77K$ 76.95K$ 123.42K
Net Debt$ -4.17M$ -5.80M$ -2.06M$ -2.05M$ -2.66M
Total Liabilities$ 2.11M$ 1.74M$ 2.08M$ 2.39M$ 3.45M
Stockholders' Equity$ 8.32M$ 9.66M$ 6.67M$ 7.18M$ 6.66M
Cash Flow
Free Cash Flow$ -2.46M$ -1.45M$ 497.65K$ 6.00K$ 131.06K
Operating Cash Flow$ -2.23M$ -1.30M$ 551.82K$ 9.16K$ 552.68K
Investing Cash Flow$ 418.20K$ -382.58K$ -450.50K$ -490.57K$ 1.32M
Financing Cash Flow$ 144.97K$ 5.75M$ 108.17K$ -28.22K$ -4.95K
Currency in USD

BioNexus Gene Lab Corp Earnings and Revenue History

BioNexus Gene Lab Corp Debt to Assets

BioNexus Gene Lab Corp Cash Flow

BioNexus Gene Lab Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis